SKYE BIOSCIENCE INC is screened out under 1 exclusion reason spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Skye Bioscience Inc. is a clinical-stage biotechnology company whose core research and development pipeline relies on animal testing. The company’s lead drug candidates, including treatments for obesity and glaucoma, require preclinical testing that involves laboratory evaluations on animals, as disclosed in its regulatory filings. This business model is inherently dependent on the commercial exploitation of animals for biomedical research.
Specific company announcements detail this reliance. In April 2023, Skye Bioscience published results showing its novel cannabinoid derivative reduced pain in an animal model, with the findings promoted in a company press release. The company is listed by Cruelty Free Investors as a firm that exploits animals. As a pharmaceutical developer without any marketed products, its entire value proposition is currently predicated on animal-based studies to advance its therapeutic candidates through the regulatory approval process.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.